AllianceBernstein’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $440K | Buy |
44,180
+11,670
| +36% | +$116K | ﹤0.01% | 2719 |
|
|
2025
Q1 | $194K | Hold |
32,510
| – | – | ﹤0.01% | 2929 |
|
|
2024
Q4 | $250K | Hold |
32,510
| – | – | ﹤0.01% | 2959 |
|
|
2024
Q3 | $332K | Sell |
32,510
-5,900
| -15% | -$60.2K | ﹤0.01% | 2870 |
|
|
2024
Q2 | $570K | Buy |
38,410
+6,580
| +21% | +$97.6K | ﹤0.01% | 2606 |
|
|
2024
Q1 | $434K | Sell |
31,830
-3,490
| -10% | -$47.6K | ﹤0.01% | 2641 |
|
|
2023
Q4 | $387K | Hold |
35,320
| – | – | ﹤0.01% | 2731 |
|
|
2023
Q3 | $387K | Sell |
35,320
-1,740
| -5% | -$19.1K | ﹤0.01% | 2696 |
|
|
2023
Q2 | $491K | Buy |
37,060
+11,760
| +46% | +$156K | ﹤0.01% | 2648 |
|
|
2023
Q1 | $344K | Sell |
25,300
-3,622
| -13% | -$49.3K | ﹤0.01% | 2719 |
|
|
2022
Q4 | $565K | Sell |
28,922
-43,857
| -60% | -$857K | ﹤0.01% | 2565 |
|
|
2022
Q3 | $1.39M | Sell |
72,779
-558,339
| -88% | -$10.6M | ﹤0.01% | 2114 |
|
|
2022
Q2 | $13M | Sell |
631,118
-486,228
| -44% | -$10M | 0.01% | 1008 |
|
|
2022
Q1 | $36M | Sell |
1,117,346
-187,867
| -14% | -$6.05M | 0.01% | 700 |
|
|
2021
Q4 | $60.8M | Sell |
1,305,213
-29,868
| -2% | -$1.39M | 0.02% | 563 |
|
|
2021
Q3 | $36M | Sell |
1,335,081
-19,997
| -1% | -$540K | 0.01% | 720 |
|
|
2021
Q2 | $34.8M | Buy |
1,355,078
+185,077
| +16% | +$4.75M | 0.01% | 731 |
|
|
2021
Q1 | $40M | Buy |
1,170,001
+71,901
| +7% | +$2.46M | 0.02% | 681 |
|
|
2020
Q4 | $37.1M | Buy |
1,098,100
+330,016
| +43% | +$11.2M | 0.02% | 668 |
|
|
2020
Q3 | $18.9M | Buy |
+768,084
| New | +$18.9M | 0.01% | 816 |
|